Stem cell therapy gives sight to four year old

NewsGuard 100/100 Score

Izabelle Evans, only four years of age, was born blind but in a medical miracle has been given sight. After a stem cell treatment in China she can see. Her parents James Evans and Hollie McHugh are “over the moon” that their daughter can finally see them. As of now she can see only 3ft away. The treatment that cost the family £50,000.

According to mother Hollie, “Because she hasn’t used her eyes before we have to remind her to use them… She went back to school and they have seen a difference too. She picks things up and holds them close to her face… A couple of days after we got back I put the Christmas tree up and she reached out to grab for the lights. Last year she wasn’t even aware we had a Christmas tree. It’s just incredible. I can’t wait for her to open her presents and experience it all for herself.” She found that Izabelle’s speech has also improved and so has her walking.

Izabelle was born with septo-optic dysplasia – a condition that affects five in one million babies. This meant that she had only a few hundred optic nerves sending information to her brain. A person needs millions to be able to see. The stem cell therapy involved injecting the spinal canal with cells taken from umbilical cords of healthy babies. The cells are then used to rebuild optic nerves. She had to stay at a hospital in the Chinese city of Tsingtao for a month.

According to Professor Chris Mason, of the UK Stem Cell Foundation, the treatments were still experimental and it would be at least 12 years before approved therapies would be available. He added, “However it does promise to give us a fantastic new tool to cure many diseases.”

Izabelle’s father James said, “We’re going to wait six months, because the stem cells continue to work for six months if she stays healthy… We’re going to keep an eye on her, see how her vision is, and then decide if we’ll go back to China to see if we can improve even more.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Stem cell therapy gives sight to four year old. News-Medical. Retrieved on April 26, 2024 from https://www.news-medical.net/news/20101216/Stem-cell-therapy-gives-sight-to-four-year-old.aspx.

  • MLA

    Mandal, Ananya. "Stem cell therapy gives sight to four year old". News-Medical. 26 April 2024. <https://www.news-medical.net/news/20101216/Stem-cell-therapy-gives-sight-to-four-year-old.aspx>.

  • Chicago

    Mandal, Ananya. "Stem cell therapy gives sight to four year old". News-Medical. https://www.news-medical.net/news/20101216/Stem-cell-therapy-gives-sight-to-four-year-old.aspx. (accessed April 26, 2024).

  • Harvard

    Mandal, Ananya. 2018. Stem cell therapy gives sight to four year old. News-Medical, viewed 26 April 2024, https://www.news-medical.net/news/20101216/Stem-cell-therapy-gives-sight-to-four-year-old.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First-of-its-kind AI tool predicts patient response to cancer drugs at single-cell resolution